Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Philip Meuleman

Faculty of Medicine and Health Sciences > Department of Diagnostic Sciences

Work address: C. Heymanslaan 10, ingang 38 (MRB2)
9000 Gent
Email: Philip.Meuleman@UGent.be
ORCID iD: 0000-0001-6821-234X

Show Sort by

Add to list
- Journal Article
- A1
- open access
Study of hepatitis E virus-4 infection in human liver-chimeric, immunodeficient, and immunocompetent mice

Laura Collignon (UGent) , Lieven Verhoye (UGent) , Renate Hakze-Van der Honing, Wim H. M. Van der Poel and Philip Meuleman (UGent)

(2022) FRONTIERS IN MICROBIOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections

P Maravelia, L Frelin, Y Ni, NC Pérez, G Ahlén, N Jagya, G Verch, Lieven Verhoye (UGent) , L Pater, M Johansson, et al.

(2021) JOURNAL OF INFECTIOUS DISEASES. 223(1). p.128-138
Add to list
- Journal Article
- A1
- open access
Inflammation alters the secretome and immunomodulatory properties of human skin-derived precursor cells

Joery De Kock, Robim Marcelino Rodrigues, Steven Branson, Lieven Verhoye (UGent) , Haaike Colemonts-Vroninks, Matthias Rombaut, Joost Boeckmans, Jessie Neuckermans, Sien Lequeue, Karolien Buyl, et al.

(2020) CELLS. 9(4).
Add to list
- Journal Article
- A1
- open access
Experimental variables that affect human hepatocyte MV transduction in liver chimeric mice

Chenhui Zou, Koen O.A. Vercauteren, Eleftherios Michailidis, Mohammad Kabbani, Irene Zoluthkin, Corrine Quirk, Luis Chiriboga, Mustafa Yazicioglu, Xavier M. Anguela, Philip Meuleman (UGent) , et al.

(2020) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 18. p.189-198
Add to list
- Journal Article
- A1
- open access
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice

Richard J. P. Brown, Birthe Tegtmeyer, Julie Sheldon, Tanvi Khera, [missing] Anggakusuma, Daniel Todt, Gabrielle Vieyres, Romy Weller, Sebastian Joecks, Yudi Zhang, et al.

(2020) SCIENCE ADVANCES. 6(45).
Add to list
- Journal Article
- A1
- open access
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes

Eleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, Linda Andrus, Cyprien Jahan, Inna Ricardo-Lax, Chenhui Zou, Mohammad Kabbani, Paul Park, Corrine Quirk, et al.

(2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1678-1688
Add to list
- Journal Article
- A1
- open access
Robust hepatitis E virus infection and transcriptional response in human hepatocytes

Daniel Todt, Martina Friesland, Nora Moeller, Dimas Praditya, Volker Kinast, Yannick Brüggemann, Leonard Knegendorf, Thomas Burkard, Joerg Steinmann, Rani Burm (UGent) , et al.

(2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1731-1741
Add to list
Updates in hepatitis E virus (HEV) field : lessons learned from human liver chimeric mice

Ibrahim M Sayed and Philip Meuleman (UGent)

(2020) REVIEWS IN MEDICAL VIROLOGY. 30(2).
Add to list
Infectivity and stability of hepatitis C virus in different perfusion solutions

Fabian A Helfritz, Verena Wanders, Denisa Bojkova, Nina Kuklinski, Sandra Westhaus, Sandra Swoboda, Thomas Minor, Philip Meuleman (UGent) , Andreas Paul, Eike Steinmann, et al.

(2019) TRANSPLANT INFECTIOUS DISEASE. 21(5).
Add to list
Hepatitis E virus prevalence in Flemish blood donors

Ann-Sofie Vercouter, Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Isabel González Fraile, Lydia Blanco, Veerle Compernolle (UGent) and Philip Meuleman (UGent)

(2019) JOURNAL OF VIRAL HEPATITIS. 26(10). p.1218-1223

1
2
3
4
…
13
14

Next →